<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5FD8030D-A271-42C1-B9E0-1DC1FEDADCA5"><gtr:id>5FD8030D-A271-42C1-B9E0-1DC1FEDADCA5</gtr:id><gtr:name>Cobra Biologics</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5FD8030D-A271-42C1-B9E0-1DC1FEDADCA5"><gtr:id>5FD8030D-A271-42C1-B9E0-1DC1FEDADCA5</gtr:id><gtr:name>Cobra Biologics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2FCA0B9D-369C-4CC5-BD69-BE5BD73A9B44"><gtr:id>2FCA0B9D-369C-4CC5-BD69-BE5BD73A9B44</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Dixon</gtr:surname><gtr:orcidId>0000-0001-9065-6764</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FM011259%2F1"><gtr:id>5A6B0EC1-098A-46A7-B850-04DE8CF27342</gtr:id><gtr:title>PeriTune - a clonal optimisation platform</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/M011259/1</gtr:grantReference><gtr:abstractText>A variety of micro-organisms including E. coli and S. cerevisiae (baker's yeast), are used in commercial bio-production processes to manufacture a number of products, ranging from high-value low-volume products, such bio-therapeutics (e.g. recombinant insulin), to mid-value products, (e.g. biocatalysts and specialised chemicals), to low-value bulk commodity products (e.g. succinic acid and biofuels). This project will seek to develop a robust clone optimsiation platform for the potential use and application in the above industrial sectors, and so would be of great benefit in a number of applied and fundamental areas of biological and biomedical R&amp;amp;D.</gtr:abstractText><gtr:technicalSummary>The aim of this collaboratory Early Stage Feasibility project is to develop a protein expression optimisation platform for the robust production of biologics. This platform will enable key bottlenecks and manufacturability challenges of recombinant proteins used in Industrial Biotechnology to be addressed. The platform will utilize the tuneable gene expression control technology RiboTite, developed at the University of Manchester. This technology operates at the level of translation initiation and permits cellular-level tuneable control of gene expression. Clones developed through the optimisation platform will be validated, demonstrated at scale, and assessed for manufacturability.</gtr:technicalSummary><gtr:potentialImpactText>As described in proposal submitted to TSB</gtr:potentialImpactText><gtr:fund><gtr:end>2016-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2015-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>121512</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cobra Biologics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with CMO for biologics production</gtr:description><gtr:id>715451A8-0E7F-46ED-A70F-F1425EA6B99C</gtr:id><gtr:impact>Too earlier to say, the collaboration has led to successful joint grant funding.</gtr:impact><gtr:outcomeId>545c9e711e2887.63519126-1</gtr:outcomeId><gtr:partnerContribution>The partners have contributed industry R&amp;amp;D and know-how</gtr:partnerContribution><gtr:piContribution>We have contributed IP, know-how, and research expertise to this collaboration</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited Speaker at European Congress on Biotechnology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>29EFDADF-C725-4D53-B21C-99152F96F607</gtr:id><gtr:impact>Q&amp;amp;A

Lead to new contacts</gtr:impact><gtr:outcomeId>56339bc17cf513.17572076</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker at the UK-South Korea Synthetic Biology Workshop. Heathrow UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0ACDD8ED-9913-4489-BED1-3FB80622B65B</gtr:id><gtr:impact>Q&amp;amp;A

New potential collaborators in Korean</gtr:impact><gtr:outcomeId>56339c8f8540a2.89827504</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute Open Day (Outreach)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B72E513B-EE4C-430D-BD53-871D4EFBCB5B</gtr:id><gtr:impact>Synthetic Biology stand at MIB open-day attended by &amp;gt;200 A levels students</gtr:impact><gtr:outcomeId>58b52f120ae867.97110822</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>iGEM Giant Jamboree</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AAB28BCE-0EEE-4E90-B16E-8371574F5983</gtr:id><gtr:impact>Synthetic Biology iGEM Giant Jamboree</gtr:impact><gtr:outcomeId>58b52f831e1a43.48228669</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://2016.igem.org/Giant_Jamboree</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker at Centre of Excellence in Biopharmaceuticals, UK 4th Annual Scientific Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0602E53D-8806-42FD-8601-13505DB75742</gtr:id><gtr:impact>Q&amp;amp;A

Contact with new potential industrial collaborators</gtr:impact><gtr:outcomeId>56339c3ddb3123.35863264</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SMART-Map Industrial Dialogue on Synthetic Biology</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53CF64FE-C0E1-4AD6-ABC5-6AE9625A3BA9</gtr:id><gtr:impact>Workshop on the responsible development of Synthetic Biology which forms part of the EU H2020 SMART-map project.</gtr:impact><gtr:outcomeId>58b531747ac559.43406467</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:url>http://projectsmartmap.eu/</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EuroScience Open Forum (ESOF)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3281E8D0-423B-455C-8022-8DF06057A26F</gtr:id><gtr:impact>EuroScience Open Forum (ESOF):

+provide an open forum for debate on science and technology and research policies in Europe
+strengthen the links between science and society
+contribute to the creation of an integrated space for science and technology in Europe, linking research organisations and policies at national and EU levels; strive for a greater role of the EU in research and
+influence science and technology policies.</gtr:impact><gtr:outcomeId>58b5301b4f9b69.15802962</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://manchester2016.esof.eu/en/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SynBioChem Workshop on Responsible Research and Innovation</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8131C7EE-06BC-4DFD-8468-E6A25146E253</gtr:id><gtr:impact>Roundtable discussant at SynBioChem Workshop on Responsible Research and Innovation</gtr:impact><gtr:outcomeId>58b531118e29c5.61120045</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FLS Community Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E5C97E7E-516D-41A6-8F4B-C09B90BA5EC8</gtr:id><gtr:impact>An outreach stand about biotechnology for the production of fragrance compounds and public opinion of synthetic biology</gtr:impact><gtr:outcomeId>58b530a0720bb3.63761938</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC CDT UCL</gtr:description><gtr:end>2020-08-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>CBC144FE-5098-4501-8D15-D9C7DB1E4566</gtr:id><gtr:outcomeId>563397c22da217.95440907</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Indonesia, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Indonesian Government Home funded PhD Srudenship</gtr:description><gtr:end>2020-08-02</gtr:end><gtr:fundingOrg>Government of Indonesia</gtr:fundingOrg><gtr:id>DCC35037-F9A3-4F31-B43D-16B91D0DF684</gtr:id><gtr:outcomeId>58b532f0486e37.33655540</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Has led to the adoption of new working practices within industrial collaborators UK-based R&amp;amp;D facility, which has led to new business opportunities.</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>7174D54F-B499-436D-BD4C-ADC61FE0978E</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d5b85dba41e4.72893338</gtr:outcomeId><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed technological capabilities to allow us to more effectively produce human therapeutic proteins from bacterial hosts</gtr:description><gtr:exploitationPathways>Further R&amp;amp;D proposed</gtr:exploitationPathways><gtr:id>66E883CF-3100-48CF-B9EB-F4967AD9FB4F</gtr:id><gtr:outcomeId>56d5b83041b981.92719474</gtr:outcomeId><gtr:sectors><gtr:sector>Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2C1E47B5-9854-48FB-9F6D-C180A0200617</gtr:id><gtr:title>Optimization of Membrane Protein Production Using Titratable Strains of E. coli.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d1d07af39adeceda3a6e1b6a6c44e36"><gtr:id>7d1d07af39adeceda3a6e1b6a6c44e36</gtr:id><gtr:otherNames>Morra R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5a9800348e35f5.24424681</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/M011259/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>17F21DBC-4946-4262-AD07-9914F6EA12F7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioengineering</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>18D298A9-FFE3-432F-B077-E3B703272E29</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biochemical engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>9031EBB8-791D-4466-9E80-80F98BCB26E1</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Protein expression</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>9A14218E-A5F9-4EB2-AAC1-C04E62C49637</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Protein folding / misfolding</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>